Literature DB >> 19066683

Treating lower pole renal stones: in defence of shock wave lithotripsy.

John Honey1.   

Abstract

Entities:  

Year:  2008        PMID: 19066683      PMCID: PMC2593604          DOI: 10.5489/cuaj.981

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  14 in total

1.  Mechanical percussion, inversion and diuresis for residual lower pole fragments after shock wave lithotripsy: a prospective, single blind, randomized controlled trial.

Authors:  K T Pace; N Tariq; S J Dyer; M J Weir; R J D'A Honey
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

2.  Incorporation of patient preferences in the treatment of upper urinary tract calculi: a decision analytical view.

Authors:  R L Kuo; P Aslan; P H Abrahamse; D B Matchar; G M Preminger
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

3.  Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of followup.

Authors:  Amy E Krambeck; Matthew T Gettman; Audrey L Rohlinger; Christine M Lohse; David E Patterson; Joseph W Segura
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

4.  Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial.

Authors:  Tarkan Soygür; Ayşegül Akbay; Sadettin Küpeli
Journal:  J Endourol       Date:  2002-04       Impact factor: 2.942

5.  Shock wave lithotripsy for renal stones is not associated with hypertension and diabetes mellitus.

Authors:  Yoshikazu Sato; Hitoshi Tanda; Shuji Kato; Shigeki Ohnishi; Hisao Nakajima; Akihito Nanbu; Toshikazu Nitta; Mikio Koroku; Keigo Akagashi; Tatsuo Hanzawa
Journal:  Urology       Date:  2008-04       Impact factor: 2.649

6.  Predictors of lower pole renal stone clearance after extracorporeal shock wave lithotripsy.

Authors:  Yasuhiro Sumino; Hiromitsu Mimata; Yoshihisa Tasaki; Hitoshi Ohno; Tetsuji Hoshino; Takeo Nomura; Yoshio Nomura
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

7.  Prospective evaluation of acute endocrine pancreatic injury as collateral damage of shock-wave lithotripsy for upper urinary tract stones.

Authors:  Gunnar Wendt-Nordahl; Patrick Krombach; Dieter Hannak; Axel Häcker; Maurice Stephan Michel; Peter Alken; Thomas Knoll
Journal:  BJU Int       Date:  2007-12       Impact factor: 5.588

8.  Quality of life after percutaneous nephrolithotomy for caliceal diverticulum and secluded lower-pole renal stones.

Authors:  Dimitrios Staios; Henry O Andrews; Taufiq Shaik; Noor N P Buchholz
Journal:  J Endourol       Date:  2007-05       Impact factor: 2.942

9.  Nephrostomy tract dilation using a balloon dilator in percutaneous renal surgery: experience with 95 cases and comparison with the fascial dilator system.

Authors:  Mut Safak; Cagatay Gögüş; Tarkan Soygür
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

10.  Upper-pole puncture in percutaneous nephrolithotomy: a retrospective review of treatment safety and efficacy.

Authors:  Asif Raza; Sami Moussa; Gordon Smith; David A Tolley
Journal:  BJU Int       Date:  2008-03       Impact factor: 5.588

View more
  3 in total

1.  Comparative Study of Lithotripsy and PCNL for 11-15 mm Lower Caliceal Calculi In Community Health Hospital.

Authors:  Narendra Haribhau Wankhade; Jayant Gadekar; Babaji B Shinde; Julie Anand Tatte
Journal:  J Clin Diagn Res       Date:  2014-06-20

Review 2.  Optimal management of lower pole stones: the direction of future travel.

Authors:  Sacha L Moore; Ewa Bres-Niewada; Paul Cook; Hannah Wells; Bhaskar K Somani
Journal:  Cent European J Urol       Date:  2016-07-11

3.  Effects of diuretic administration on outcomes of extracorporeal shockwave lithotripsy: A systematic review and meta-analysis.

Authors:  Zhenghao Wang; Yunjin Bai; Jia Wang
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.